Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.21NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.2.21NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BA.2.21NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.21NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.21NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BA.2.21NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.21NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.21NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.2.21NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.2.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
BA.2.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.21NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.21ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
BA.2.21ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
BA.2.21ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
BA.2.21ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
BA.2.21ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.2.21ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
BA.2.21SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.21SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BA.2.21SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
BA.2.21SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-22193.2Japan
BA.2.21SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
BA.2.21SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
BA.2.31ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.2.31ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.2.31ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
BA.2.31ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
BA.2.31ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
BA.2.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.31ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
BA.2.31ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
BA.2.31ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
BA.2.31ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.2.31ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-3521.26Germany
BA.2.31ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
BA.2.31ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
BA.2.31ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BA.2.31ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BA.2.31ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
BA.2.31ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.2.31ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
BA.2.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.31SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used